UVADEX (methoxsalen)
ANTINEOPLASTIC - PHOTOSENSITIZERS · CUTANEOUS T-CELL LYMPHOMA
THERAKOS INC
Drug class
Psoralens, Systemic
Systemic psoralens are orally administered furocoumarin photosensitizers used in photochemotherapy regimens alongside controlled ultraviolet A radiation, commonly known as PUVA therapy. Read more about Psoralens, Systemic
3 drugs in this class 2 manufacturers
Drugs in Psoralens, Systemic
METHOXSALEN (methoxsalen, rapid)
ANTIPSORIATICS · SEVERE RECALCITRANT PSORIASIS
STRIDES PHARMA
METHOXSALEN
ANTIPSORIATICS · SEVERE RECALCITRANT PSORIASIS
STRIDES PHARMA
Filter & compare in the drug finder →
Opens the drug finder with Psoralens, Systemic preselected. Add indication or manufacturer filters there.
Systemic psoralens are orally administered furocoumarin photosensitizers used in photochemotherapy regimens alongside controlled ultraviolet A radiation, commonly known as PUVA therapy.
Following systemic absorption and distribution to the skin, these compounds intercalate into cellular DNA; subsequent UVA exposure activates them to form interstrand cross-links and monoadducts with pyrimidine bases, thereby inhibiting DNA synthesis, suppressing rapid cellular proliferation, and exerting localized immunomodulatory effects.
Systemic psoralens, represented predominantly by methoxsalen, are indicated for the management of severe, recalcitrant psoriasis, extensive vitiligo, and cutaneous T-cell lymphoma, such as mycosis fungoides.
-
fda.gov
Systemic psoralens are orally administered furocoumarin photosensitizers used in photochemotherapy regimens alongside controlled ultraviolet A radiation, commonly known as PUVA therapy Systemic psoralens, represented predominantly by methoxsalen, are indicated for the management of severe, recalcitrant psoriasis, extensive vitiligo, and cutaneous T-cell lymphoma, such as mycosis fungoides
-
nih.gov
Systemic psoralens are orally administered furocoumarin photosensitizers used in photochemotherapy regimens alongside controlled ultraviolet A radiation, commonly known as PUVA therapy
-
nih.gov
Following systemic absorption and distribution to the skin, these compounds intercalate into cellular DNA; subsequent UVA exposure activates them to form interstrand cross-links and monoadducts with pyrimidine bases, thereby inhibiting DNA synthesis, suppressing rapid cellular proliferation, and exerting localized immunomodulatory effects
-
nih.gov
Following systemic absorption and distribution to the skin, these compounds intercalate into cellular DNA; subsequent UVA exposure activates them to form interstrand cross-links and monoadducts with pyrimidine bases, thereby inhibiting DNA synthesis, suppressing rapid cellular proliferation, and exerting localized immunomodulatory effects Systemic psoralens, represented predominantly by methoxsalen, are indicated for the management of severe, recalcitrant psoriasis, extensive vitiligo, and cutan...
-
bcbsfl.com
Systemic psoralens, represented predominantly by methoxsalen, are indicated for the management of severe, recalcitrant psoriasis, extensive vitiligo, and cutaneous T-cell lymphoma, such as mycosis fungoides
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.